Expression of Replication-Licensing Factors MCM2 and MCM3 in Normal, Hyperplastic, and Carcinomatous Endometrium: Correlation With Expression of Ki-67 and Estrogen and Progesterone Receptors

Minichromosome maintenance (MCM) proteins are essential for cell cycling due to their function as replication-licensing factors. The aim of the present study was to investigate the clinicopathologic implications of the MCM2 and MCM3 in endometrial carcinogenesis. The authors investigated the immunohistochemical expression of MCM2 and MCM3, Ki-67, estrogen receptor, and progesterone receptor in 23 normal endometria, 9 endometrial hyperplasias, and 60 endometrial carcinomas. In the normal endometrial glands, the expression of MCM2 and MCM3 was significantly higher in the proliferative phase than in the secretory phase and was strongly correlated with Ki-67 expression. Similar correlation between the expression of MCMs and Ki-67 was also found in endometrial hyperplasia. In endometrial carcinomas, however, the expression of MCM2 and MCM3 was significantly lower than that in the normal proliferative endometrium. There was only a weak correlation between MCM2 and Ki-67, and no significant correlation between MCM3 and Ki-67 expression. These findings suggest that the expression of MCM2 and MCM3 directly reflects cell proliferation in normal and hyperplastic endometria. In endometrial carcinomas, however, there is a discrepancy between the expression of MCMs and cell proliferation, suggesting that the replication-licensing system may be aberrant in endometrial carcinomas.

[1]  J. Blow,et al.  The Xenopus origin recognition complex is essential for DNA replication and MCM binding to chromatin , 1996, Current Biology.

[2]  G. Williams,et al.  Minichromosome maintenance proteins as biological markers of dysplasia and malignancy. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  M. Fujita,et al.  Immunolocalization of hCDC47 protein in normal and neoplastic human tissues and its relation to growth , 1997, International journal of cancer.

[4]  T. Coleman,et al.  The Xenopus Cdc6 Protein Is Essential for the Initiation of a Single Round of DNA Replication in Cell-Free Extracts , 1996, Cell.

[5]  H. Nojima,et al.  Identification of the yeast MCM3-related protein as a component of xenopus DNA replication licensing factor , 1995, Cell.

[6]  B. Tye.  MCM proteins in DNA replication. , 1999, Annual review of biochemistry.

[7]  T. Nikaido,et al.  Stepwise abnormality of sex steroid hormone receptors, tumor suppressor gene products (p53 and Rb), and cyclin E in uterine endometrioid carcinoma , 1996, Cancer.

[8]  James P. J. Chong,et al.  Purification of an MCM-containing complex as a component of the DNA replication licensing system , 1995, Nature.

[9]  M. Nap,et al.  The Patterns of Expression of an Apoptosis-Related CK18 Neoepitope, the bcl-2 Proto-Oncogene, and the Ki67 Proliferation Marker in Normal, Hyperplastic, and Malignant Endometrium , 2000, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[10]  A. Vassilev,et al.  Expression of the nuclear protein mitotin in differentiating in vitro HL 60 cells , 1991, Biology of the cell.

[11]  K. Nasmyth,et al.  Loading of an Mcm Protein onto DNA Replication Origins Is Regulated by Cdc6p and CDKs , 1997, Cell.

[12]  T. Masuda,et al.  Growth potential of endometrial cancers assessed by a Ki-67 Ag/DNA dual-color flow-cytometric assay. , 1992, Gynecologic oncology.

[13]  K. Sugimoto,et al.  DNA polymerase alpha associated protein P1, a murine homolog of yeast MCM3, changes its intranuclear distribution during the DNA synthetic period. , 1994, The EMBO journal.

[14]  L. Akslen,et al.  Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  T. Nikaido,et al.  Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid‐type endometrial carcinoma , 1997, Cancer.

[16]  T. Nikaido,et al.  Localization of apoptotic cells within the human endometrium and correlation between apoptosis and p21 expression. , 1998, Molecular human reproduction.

[17]  S. Kearsey,et al.  MCM proteins: evolution, properties, and role in DNA replication. , 1998, Biochimica et biophysica acta.

[18]  L. Drury,et al.  Cdc6p-dependent loading of Mcm proteins onto pre-replicative chromatin in budding yeast. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Werness,et al.  HsMCM2/BM28: a novel proliferation marker for human tumors and normal tissues. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[20]  R. Laskey,et al.  MCM3 complex required for cell cycle regulation of DNA replication in vertebrate cells , 1995, Nature.

[21]  H. Stein,et al.  Production of a monoclonal antibody reactive with human dendritic reticulum cells and its use in the immunohistological analysis of lymphoid tissue. , 1983, Journal of clinical pathology.

[22]  T. Nikaido,et al.  Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle. , 1996, Molecular human reproduction.

[23]  A. Attaran,et al.  BM28, a human member of the MCM2-3-5 family, is displaced from chromatin during DNA replication , 1995, The Journal of cell biology.